Welcome back to Stockhouse
Member Sign In

Email or Username:

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Enter your email address:
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

Get our best content in your email.

You are already a member! Please enter your password to sign in.
Quote  |  Bullboard  |  News  |  Opinion  |  Level II  |  Charts  |  Profile  |  Financials  |  Options  |  Price History  |  Analysts  |  Earnings  |  Insiders

Vivus Inc VVUS

Sector: Healthcare | Sub-Sector: Biotechnology

Vivus is a biopharmaceutical company engaged in the development and commercialization of therapeutic products for large underserved markets. Its product line includes Qsymia for sleep apnea, STENDRA for erectile dysfunction.
Price: $1.52 Volume: 1.6m
Change: $-0.21 % Change: -12.14%
Day High/Low: 1.69/1.28 52 Week High/Low: 5.13/1.61
Last Traded: July 31, 2015 06:51 Transaction Volume: 100
Open: 1.69 Previous Close: 1.73
Bid: 1.52 Ask: 1.53
Bid Size: 73800 Ask Size: 900
Market Cap: 157.8m Shares Out: 103.8m
PE Ratio: N/A Dividend Yield: N/A


Trading the ABC sentiment shifts ahead of the crowd

In all cases what traders really need to spot ahead of the masses of investors is a subtle shift in

David Banister   December 18, 2012
0 stars

Art of trading penny stocks

If you look at the top 10 performing stocks on U.S. exchanges for 2012 to date, you’ll see that seven of these stocks are small caps with market caps of $1 billion or less

Ryan Fitzwater   April 10, 2012
0 stars

Stock picks including a coal play

Some pharma recommendations also provided

J.W. Cotton   November 4, 2009
0 stars

Latest Bullboard Posts

  • trouble is right...

    0 stars

    Coroners report: Selling Short Term investments continuously for the last 5 quarters to pay groceries. Latest quarterly cash flow...

    2 stars

  • VVUS is in deep trouble

    0 stars

    Share prices are dropping like a rock..... No sales volume, income, or truely useful product that can't be prescribed in generic form...

    3 stars

  • Vivus Board And CEO changes

    0 stars

    This is exactly what this company needed; a capable proven CEO that knows pharmaceutical marketing and a Board dominated by First...

    1.5 stars

  • RE: Big Troubles For VVUS & Investors...

    0 stars

    Oh..... another HAIR CUT is happening today as well! DOWN ANOTHER 5%   Wonder where it will be when the bell rings today????

    3 stars

  • Big Troubles For VVUS & Investors...

    0 stars

    This is a direct quote from The Streets Gregg Greenberg: VERY INTERESTING AND INFORMATIVE. The sales and marketing folks at Vivus (VVUS...

    3 stars